These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8108211)

  • 21. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy.
    Kurikka S; Käyhty H; Saarinen L; Rönnberg PR; Eskola J; Mäkelä PH
    J Infect Dis; 1995 Nov; 172(5):1268-72. PubMed ID: 7594663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants.
    Washburn LK; O'Shea TM; Gillis DC; Block SM; Abramson JS
    J Pediatr; 1993 Nov; 123(5):791-4. PubMed ID: 8229493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Daum RS; Siber GR; Ballanco GA; Sood SK
    J Infect Dis; 1991 Dec; 164(6):1154-9. PubMed ID: 1955715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants.
    Mulholland EK; Ahonkhai VI; Greenwood AM; Jonas LC; Lukacs LJ; Mink CM; Staub JM; Todd J; Vella PP; Greenwood BM
    Pediatr Infect Dis J; 1993 Aug; 12(8):632-7. PubMed ID: 8414774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the Centers for Disease Control and Prevention. Committee on immunization practices: PedvaxHIB lots with questionable immunogenicity.
    JAMA; 1992 Dec; 268(22):3186. PubMed ID: 1433752
    [No Abstract]   [Full Text] [Related]  

  • 28. The immunogenicity of Hemophilus influenzae type B polysaccharide-Neisseria meningitidis group B outer membrane protein complex vaccine in infants and young children.
    Shapiro ED; Capobianco LA; Berg AT; Zitt MQ
    J Infect Dis; 1989 Dec; 160(6):1064-7. PubMed ID: 2511254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ; Deck RR; Liu MA
    J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants.
    Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM
    Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.
    Santosham M; Rivin B; Wolff M; Reid R; Newcomer W; Letson GW; Almeido-Hill J; Thompson C; Siber GR
    J Infect Dis; 1992 Jun; 165 Suppl 1():S144-51. PubMed ID: 1588150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity.
    Latz E; Franko J; Golenbock DT; Schreiber JR
    J Immunol; 2004 Feb; 172(4):2431-8. PubMed ID: 14764714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advisory Committee on Immunization Practices update: report of PedvaxHIB lots with questionable immunogenicity.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(46):878-9. PubMed ID: 1435679
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
    Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
    JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIB.
    Mendelman PM; Feeley L; Bird S; Staub T; Matthews H; Del Beccaro MA; Overturf G; Lee A; Ellis R; Staub J; Szymanski S; Donnelly J; Hennessey JP; Kniskern P
    Vaccine; 1997; 15(6-7):775-81. PubMed ID: 9178481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
    Granoff DM; Holmes SJ
    Vaccine; 1991 Jun; 9 Suppl():S30-4; discussion S42-3. PubMed ID: 1891954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
    Wong VK; Kim KS
    Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.